Alina Solomon,Ruth Stephen,Daniele Altomare,Emmanuel Carrera,Giovanni B Frisoni,Jenni Kulmala,José Luis Molinuevo,Peter Nilsson,Tiia Ngandu,Federica Ribaldi,Bruno Vellas,Philip Scheltens,Miia Kivipelto,European Task Force for Brain Health Services,Marc Abramowicz,Frederik Barkhof,Marcelo Berthier,Melanie Bieler,Kaj Blennow,Carol Brayne,Andrea Brioschi,Gael Chételat,Chantal Csajka,Jean-François Demonet,Alessandra Dodich,Bruno Dubois,Valentina Garibotto,Jean Georges,Samia Hurst,Frank Jessen,David Llewellyn,Laura Mcwhirter,Richard Milne,Carolina Minguillón,Carlo Miniussi,Peter M Nilsson,Janice Ranson,Craig Ritchie,Cornelia van Duijn,Wiesje van der Flier,Leonie Visser

Abstract:Although prevention of dementia and late-life cognitive decline is a major public health priority, there are currently no generally established prevention strategies or operational models for implementing such strategies into practice. This article is a narrative review of available evidence from multidomain dementia prevention trials targeting several risk factors and disease mechanisms simultaneously, in individuals without dementia at baseline. Based on the findings, we formulate recommendations for implementing precision risk reduction strategies into new services called Brain Health Services. A literature search was conducted using medical databases (MEDLINE via PubMed and SCOPUS) to select relevant studies: non-pharmacological multidomain interventions (i.e., combining two or more intervention domains), target population including individuals without dementia, and primary outcomes including cognitive/functional performance changes and/or incident cognitive impairment or dementia. Further literature searches covered the following topics: sub-group analyses assessing potential modifiers for the intervention effect on cognition in the multidomain prevention trials, dementia risk scores used as surrogate outcomes in multidomain prevention trials, dementia risk scores in relation to brain pathology markers, and cardiovascular risk scores in relation to dementia. Multidomain intervention studies conducted so far appear to have mixed results and substantial variability in target populations, format and intensity of interventions, choice of control conditions, and outcome measures. Most trials were conducted in high-income countries. The differences in design between the larger, longer-term trials that met vs. did not meet their primary outcomes suggest that multidomain intervention effectiveness may be dependent on a precision prevention approach, i.e., successfully identifying the at-risk groups who are most likely to benefit. One such successful trial has already developed an operational model for implementing the intervention into practice. Evidence on the efficacy of risk reduction interventions is promising, but not yet conclusive. More long-term multidomain randomized controlled trials are needed to fill the current evidence gaps, especially concerning low- and middle-income countries and integration of dementia prevention with existing cerebrovascular prevention programs. A precision risk reduction approach may be most effective for dementia prevention. Such an approach could be implemented in Brain Health Services.

FROM THE WHO RESEARCH PRIORITIES AND RESEARCH PORTFOLIO ANALYSIS TO THE IDENTIFICATION OF RESEARCH GAPS TO REDUCE THE GLOBAL BURDEN OF DEMENTIA

The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact

Ageing and Dementia in Low and Middle Income Countries–using Research to Engage with Public and Policy Makers

A Systematic Review of Dementia Research Priorities

BRIDGING THE TRANSLATION GAP: FROM DEMENTIA RISK ASSESSMENT TO ADVICE ON RISK REDUCTION

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers

Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's Association

Promoting diverse perspectives: Addressing health disparities related to Alzheimer's and all dementias

Basic, Translational, and Clinical Research on Dementia

Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research

Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Identifying Dementia research priority for Qatar national dementia research plan: A Cross-sectional Survey

Epidemiological Insights, Risk Factors and Prevention Pathways

Global Dementia Strategy: Current Stage and Challenges

Expanding the scope of health disparities research in Alzheimer's disease and related dementias

Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6

Dementia Research in 2022: Advancing Steadily on Reflection

Tackling Dementia Globally: the Global Dementia Prevention Program (glodepp) Collaboration

Current Alzheimer disease research highlights: evidence for novel risk factors

From Plan to Impact ‐ progress towards targets of the WHO Global action plan on dementia